title: The modality of dialysis treatment: does it influence the response to erythropoietin treatment?
authors.forename: F
authors.initials: F
authors.lastname: Locatelli
authors.forename: L
authors.initials: L
authors.lastname: Del Vecchio
authors.forename: S
authors.initials: S
authors.lastname: Andrulli
mesh_terms: D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D004351:Drug Resistance; D004921:Erythropoietin / Q000627:therapeutic use*; D005112:Extracorporeal Circulation / Q000009:adverse effects; D017583:Hemodiafiltration / Q000009:adverse effects / Q000379:methods; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods*
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin